Upperton Pharma Solutions

Upperton Pharma Solutions is a science-led, integrated CDMO headquartered in Nottingham, UK, with a focus on drug delivery for small molecules. Founded in 2004, it operates from a single, award-winning 60,000 sqft facility, offering end-to-end services from formulation development to GMP manufacturing for clinical trials. The company differentiates itself through a nimble, project-focused approach with executive oversight on each program, catering primarily to biotech clients advancing products through pre-clinical to late-phase clinical stages.

Integrated CDMO services with specialized expertise in formulation development and GMP manufacturing for oral solids, nasal, pulmonary (dry powder inhalation), and parenteral dosage forms. Operates a single-site, 60,000 sqft facility for seamless development through commercial supply.

Upperton competes in the fragmented global CDMO market, facing competition from large, multi-site players (e.g., Lonza, Catalent) and other specialized European CDMOs. Its primary differentiation is its integrated, single-site service model for complex dosage forms and its recent foray into sterile manufacturing, targeting the niche for small-to-medium batch clinical supply.